In my controversial opinion, no one cares about high performance results anymore, investors accept the outperformance to date vis-à-vie competitors etc. we’ve seen dozens of outperformance presentations over the years, just doesn’t carry any weight with retail investors, hasn’t driven SP improvement, hasn’t led to a partnership or competitors looking to acquire, nothing major. The focus is now on can this technology ever make it to commercialisation, is this the team to progress that. Jury is out on whether WP is that person, he hasn’t managed to make any real traction in the market even supported by amazing results presentations. Just my opinion, fire away.
- Forums
- ASX - By Stock
- AVR
- AVR results presentation at CRT 24 Washington DC 9th to 12th March
AVR results presentation at CRT 24 Washington DC 9th to 12th March, page-29
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.31 |
Change
-0.600(6.05%) |
Mkt cap ! $196.8M |
Open | High | Low | Value | Volume |
$9.50 | $9.77 | $9.30 | $137.9K | 14.58K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 800 | $9.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.48 | 364 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 800 | 9.310 |
2 | 2415 | 9.300 |
2 | 1044 | 9.250 |
2 | 412 | 9.200 |
1 | 1000 | 9.010 |
Price($) | Vol. | No. |
---|---|---|
9.480 | 364 | 4 |
9.490 | 180 | 1 |
9.500 | 180 | 1 |
9.520 | 180 | 1 |
9.850 | 1000 | 1 |
Last trade - 15.46pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online